Short and long term effects of clinical DBT-PE for patients with severe posttraumatic stress disorder and co-morbid psychopathology
- Conditions
- posttraumatic stress disorderPTSD10002861
- Registration Number
- NL-OMON46167
- Lead Sponsor
- GGZ Friesland (Leeuwarden)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion criteria are: (1) age 18-65 years old; (2) meeting the DSM-IV-defined diagnosis criteria of PTSD ; (3) meeting the diagnostic criteria for at least one comorbid psychiatric disorder
Exclusion criteria for this research are current psychosis, substance dependence, a body-mass-index < 17, antisocial personality disorder, possible intellectual disability defined as a score on the screening instrument SCIL<20 (see 8.3), medical conditions contradicting the exposure protocol (their family doctor or medical specialist will be consulted whether it is safe to carry out the exposure protocol) and war veterans. For safety reasons, patients with a recent suicide attempt (in the last three months) will not be included. Because of their negative influence on cognitive functioning like memory, attendance and information processing, patients (frequently) using benzodiazepines are excluded from study participation.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary outcome measure is presence and severity of PTSD. </p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary outcome measures are: severity of borderline personality disorder<br /><br>symptoms, dissociative symptoms, non-suicidal selfharm, suicidal ideation,<br /><br>social functioning, quality of life, care consumption.</p><br>